129 related articles for article (PubMed ID: 22010448)
1. [Side effects of the HMG-CoA reductase inhibitors (statins). Lupus erythematosus induced by Atorvastatin therapy].
Hydzik P; Szpak D
Przegl Lek; 2011; 68(8):495-8. PubMed ID: 22010448
[TBL] [Abstract][Full Text] [Related]
2. Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine.
Maltz HC; Balog DL; Cheigh JS
Ann Pharmacother; 1999 Nov; 33(11):1176-9. PubMed ID: 10573315
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin-induced cholestatic hepatitis in a young woman with systemic lupus erythematosus. Grupo Lupus Virgen de las Nieves.
Jiménez-Alonso J; Osorio JM; Gutiérrez-Cabello F; López de la Osa A; León L; Mediavilla García JD
Arch Intern Med; 1999 Aug 9-23; 159(15):1811-2. PubMed ID: 10448788
[No Abstract] [Full Text] [Related]
4. [Statin-induced dysphagia].
Edholm B
Ugeskr Laeger; 2010 Feb; 172(7):544-5. PubMed ID: 20156405
[TBL] [Abstract][Full Text] [Related]
5. Statin-induced rhabdomyolysis and dermatomyositis: a rare combination.
Cannon CS
JAAPA; 2012 Aug; 25(8):30, 32-3. PubMed ID: 22928274
[No Abstract] [Full Text] [Related]
6. Summaries for patients. Muscle abnormalities in four patients taking statins to treat unfavorable cholesterol levels.
Ann Intern Med; 2002 Oct; 137(7):I45. PubMed ID: 12353973
[No Abstract] [Full Text] [Related]
7. Atorvastatin-induced dermatomyositis.
Noël B; Cerottini JP; Panizzon RG
Am J Med; 2001 Jun; 110(8):670-1. PubMed ID: 11388341
[No Abstract] [Full Text] [Related]
8. Cholestatic jaundice induced by atorvastatin: a possible association with antimitochondrial antibodies.
Minha S; Golzman G; Adar I; Rapoport M
Isr Med Assoc J; 2009 Jul; 11(7):440-1. PubMed ID: 19911499
[No Abstract] [Full Text] [Related]
9. Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia.
Malhotra HS; Goa KL
Drugs; 2001; 61(12):1835-81. PubMed ID: 11693468
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin-induced dermatomyositis in a 47-year-old woman with Sjögren's syndrome.
Komai E; Takemoto M; Yokote K
Acta Cardiol; 2015 Jun; 70(3):373. PubMed ID: 26226717
[No Abstract] [Full Text] [Related]
11. Atorvastatin-induced severe thrombocytopenia.
González-Ponte ML; González-Ruiz M; Duvós E; Gutiérrez-Iñiguez MA; Olalla JI; Conde E
Lancet; 1998 Oct; 352(9136):1284. PubMed ID: 9788465
[No Abstract] [Full Text] [Related]
12. Toxic epidermal necrolysis from atorvastatin.
Pfeiffer CM; Kazenoff S; Rothberg HD
JAMA; 1998 May; 279(20):1613-4. PubMed ID: 9613909
[No Abstract] [Full Text] [Related]
13. Unrecognized side effect of statin treatment: unilateral blepharoptosis.
Ertas FS; Ertaş NM; Gulec S; Atmaca Y; Tanju S; Sener C; Erol C
Ophthalmic Plast Reconstr Surg; 2006; 22(3):222-4. PubMed ID: 16714939
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin-induced reversible positive antinuclear antibodies.
Jiménez-Alonso J; Jaimez L; Sabio JM; Hidalgo C; Leon L
Am J Med; 2002 Mar; 112(4):329-30. PubMed ID: 11893380
[No Abstract] [Full Text] [Related]
15. Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias.
Yee HS; Fong NT
Ann Pharmacother; 1998 Oct; 32(10):1030-43. PubMed ID: 9793596
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin calcium: an addition to HMG-CoA reductase inhibitors.
Chong PH; Seeger JD
Pharmacotherapy; 1997; 17(6):1157-77. PubMed ID: 9399600
[TBL] [Abstract][Full Text] [Related]
17. An overview of the clinical safety profile of atorvastatin (lipitor), a new HMG-CoA reductase inhibitor.
Black DM; Bakker-Arkema RG; Nawrocki JW
Arch Intern Med; 1998 Mar; 158(6):577-84. PubMed ID: 9521221
[TBL] [Abstract][Full Text] [Related]
18. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
Paradis JM; LeLorier J
N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309744
[No Abstract] [Full Text] [Related]
19. [Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS)].
Gressier L; Pruvost-Balland C; Dubertret L; Viguier M
Ann Dermatol Venereol; 2009 Jan; 136(1):50-3. PubMed ID: 19171231
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the frequency of adverse events in patients treated with atorvastatin or simvastatin.
Abourjaily HM; Alsheikh-Ali AA; Karas RH
Am J Cardiol; 2003 Apr; 91(8):999-1002, A7. PubMed ID: 12686348
[No Abstract] [Full Text] [Related]
[Next] [New Search]
